RhumbLine Advisers’s Apogee Therapeutics APGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.1M Buy
48,678
+2,707
+6% +$197K ﹤0.01% 1501
2025
Q4
$3.47M Sell
45,971
-1,828
-4% -$115K ﹤0.01% 1590
2025
Q3
$1.9M Sell
47,799
-1,417
-3% -$54.1K ﹤0.01% 1940
2025
Q2
$2.14M Sell
49,216
-5,169
-10% -$197K ﹤0.01% 1848
2025
Q1
$2.03M Buy
54,385
+1,665
+3% +$64.4K ﹤0.01% 1801
2024
Q4
$2.39M Buy
52,720
+1,750
+3% +$89.2K ﹤0.01% 1789
2024
Q3
$2.99M Buy
50,970
+1,535
+3% +$73.5K ﹤0.01% 1681
2024
Q2
$1.95M Sell
49,435
-6,261
-11% -$304K ﹤0.01% 1900
2024
Q1
$3.7M Buy
55,696
+28,468
+105% +$1.24M ﹤0.01% 1578
2023
Q4
$761K Buy
27,228
+908
+3% +$18.2K ﹤0.01% 2419
2023
Q3
$561K Buy
+26,320
New +$580K ﹤0.01% 2557

Other funds holding APGE